In-hospital M | HRs | 95%CI | P value | Adverse event | HRs | 95%CI | P value |
---|---|---|---|---|---|---|---|
Model 1 | |||||||
Quartile 1 | 1.000 | Quartile 1 | 1.000 | ||||
Quartile 2 | 3.524 | 0.847–14.665 | 0.083 | Quartile 2 | 1.577 | 0.758–3.282 | 0.223 |
Quartile 3 | 8.864 | 2.201–35.693 | 0.002 | Quartile 3 | 1.764 | 0.843–3.692 | 0.132 |
Quartile 4 | 7.579 | 1.832–31.351 | 0.005 | Quartile 4 | 2.257 | 1.048–4.864 | 0.038 |
CPB | 1.018 | 1.010–1.026 | < 0.001 | CPB | 1.010 | 1.004–1.016 | 0.001 |
Cross-clamping | 1.006 | 0.992–0.979 | 0.272 | Cross-clamping | 0.995 | 0.986–1.006 | 0.376 |
Renal dysfunction | 6.955 | 2.126–22.756 | 0.001 | Renal dysfunction | 4.029 | 1.365–11.889 | 0.012 |
BMI | 1.090 | 1.017–1.169 | 0.015 | ||||
Model 2 | |||||||
Elevated WBCc | 3.104 | 1.382–6.972 | 0.006 | Elevated WBCc | 1.801 | 1.068–3.037 | 0.027 |
CPB | 1.018 | 1.010–1.026 | < 0.001 | CPB | 1.011 | 1.005–1.017 | < 0.001 |
Cross-clamping | 0.993 | 0.980–1.007 | 0.333 | Cross-clamping | 0.995 | 0.985–1.005 | 0.371 |
Renal dysfunction | 6.718 | 2.132–21.169 | 0.001 | Renal dysfunction | 4.011 | 1.373–11.719 | 0.011 |
BMI | 1.089 | 1.016–1.168 | 0.016 |